| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Royalty Pharma Plc (RPRX) has 15 insiders with recent SEC Form 4 filings, including 0 buys and 18 sells. RPRX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 941.0K | $47.79M | - | |
| VP | 658.5K | $33.45M | - | |
| Dir | 194.8K | $9.90M | - | |
| Dir | 81.4K | $4.13M | - | |
| ? | 73.1K | $3.71M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 27, 2022 | Lloyd George W.71 | EVP, Investments &GC | Sell | 75,100 | $43.25 | $3,248,199.30 | -3.8% | -4.7% | -28.4% | |
| Jul 26, 2022 | Urist Marshall73 | EVP, Research &Investments | Sell | 23,334 | $43.18 | $1,007,446.48 | -54.2% | -3.6% | -26.8% | |
| Jun 29, 2022 | Riggs Rory B67 | Director | Sell | 30,000 | $42.17 | $1,265,238.00 | -6.6% | -4.0% | -26.7% | |
| Jun 24, 2022 | Urist Marshall73 | EVP, Research &Investments | Sell | 23,333 | $43.19 | $1,007,693.94 | -50.0% | -4.5% | -27.7% | |
| Jun 8, 2022 | Reddoch James F.66 | EVP &Chief Scientific Officer | Sell | 100,000 | $41.56 | $4,155,900.00 | -9.8% | +1.4% | -16.0% | |
| May 27, 2022 | Reddoch James F.66 | EVP &Chief Scientific Officer | Sell | 75,000 | $41.08 | $3,081,007.50 | -6.8% | +6.2% | -20.9% | |
| May 27, 2022 | Lloyd George W.71 | EVP, Investments &GC | Sell | 100,000 | $40.29 | $4,029,091.25 | -10.3% | +6.2% | -20.9% | |
| May 23, 2022 | Lloyd George W.71 | EVP, Investments &GC | Sell | 100,000 | $40.27 | $4,026,770.00 | -15.9% | +9.4% | -16.7% | |
| May 20, 2022 | Riggs Rory B67 | Director | Sell | 150,000 | $39.42 | $5,913,306.17 | -12.7% | +12.2% | -14.0% | |
| May 19, 2022 | Reddoch James F.66 | EVP &Chief Scientific Officer | Sell | 75,000 | $40.44 | $3,033,127.50 | -6.4% | +12.2% | -14.5% |